DALLAS — A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...

Essentially overnight, people began making copies at a rate that was orders of magnitude higher than anyone had believed possible. And the rate is still growing.